Biochemicals known as prostaglandins are challenging targets for synthetic organic chemistry. Yet by channelling the reactivity of a simple reactant, a powerful synthesis of one such compound has been achieved. See Letter p.278
Chemical messengers called prostaglandins are present in nearly all mammalian tissues. These elusive molecules mediate an extraordinary number of biological processes — including the regulation of body temperature, the contraction and relaxation of the human uterus, the aggregation of platelets in blood and cellular responses to inflammation. They have therefore been the targets of wide-ranging research1 since the 1930s. In particular, their unique molecular architectures and great therapeutic potential have fired the creative imagination of synthetic organic chemists2,3. Writing on page 278 of this issue, Coulthard et al.4 report one of the cleverest syntheses of one such molecule, prostaglandin F2α (PGF2α), to date. The conciseness of their approach may open up new opportunities for drug discovery.
Prostaglandins contain two fat-soluble hydrocarbon chains on opposite sides of a ring of five carbon atoms (Fig. 1). Nature synthesizes PGF2α and its analogues from arachidonic acid (a polyunsaturated fatty acid) and two molecules of oxygen, with a little help from some key enzymes. Although nearly every nucleated cell is capable of biosynthesizing prostaglandins, these compounds are short-lived and exceedingly difficult to isolate from biological samples. Since the late 1960s, chemists have therefore devised creative strategies for producing prostaglandins from simple chemicals in the laboratory. The development of dependable laboratory syntheses has contributed substantially to our knowledge of the compounds' remarkable range of pharmacological properties, as well as their relevance to human health.
Ideas about the preparation of PGF2α have resulted in a diversity of pathways5,6,7,8,9 — a diversity that demonstrates how well the principles of organic chemistry can be used to plan and execute synthetic routes to structurally complex molecules (Fig. 1). The approach now reported by Coulthard et al. will be praised for its remarkable brevity and for the bold strategy that guided it. The structural relationship between the simple starting material, succindialdehyde, and the coveted target is distant, and yet the authors perceived that a union of two molecules of succindialdehyde in a single laboratory operation might produce an intermediate hemiacetal compound that is tantalizingly close to the structure of PGF2α (Fig. 2).
The risky aspect of the authors' strategy concerns the intrinsic reactivity of succindialdehyde and its potential to take part in undesired, polymer-forming reactions. Few chemists, even those of adventurous spirit, would have believed that a useful synthesis of the hemiacetal could be achieved as Coulthard et al. anticipated, through the direct pairing of two molecules of succindialdehyde in sequential carbon–carbon-bond-forming reactions known as aldol reactions. The great thing is that, not only did this direct approach work well, but it also achieved high stereoselectivity — it produced mostly one mirror-image isomer (enantiomer) of the product. This is crucial, because the biological activity of prostaglandins depends on their enantiomeric form.
The authors discovered that the sequential addition of two organic catalysts to a solution of succindialdehyde is key to the formation of the desired hemiacetal. The first catalyst was the amino acid proline, and the second was an amine salt. The development of this process was supported by earlier studies of proline-catalysed aldol reactions10,11,12 and ring-forming aldol reactions induced by amine salts13 at room temperature.
Although the yield of hemiacetal isolated from the reaction was moderate (20%), Coulthard et al. removed most of the undesired oligomeric side products by filtration. A simple chromatographic purification step then afforded the product as the major component of a 99:1 mixture of enantiomers. Any possible concerns about the yield for this impressive transformation are assuaged by the authors' demonstration that 15 grams of a key prostaglandin building block (an acetal; Fig. 2) can be produced in only two steps from succindialdehyde — a large quantity to take forward for the rest of the synthesis.
With its ring of five carbon atoms and newly formed stereogenic centres (carbon atoms around which different geometric arrangements of bonds generate different enantiomers), the acetal building block is a close approximation of the core structure of the prostaglandins. By exploiting the reactive alkene group and the rigid molecular shape of the building block, Coulthard et al. attached one of the two hydrocarbon side chains of PGF2α to the desired site on the five-membered ring. Then, in the final phase of the synthesis, the authors efficiently connected the second side chain using a reaction developed by E. J. Corey in his influential syntheses of prostaglandins5. In all, only seven operations were needed to transmute the simple compound succindialdehyde into PGF2α. For comparison, Corey's synthesis required 17 steps, starting from the simple molecule cyclopentadiene.
Finding a way to prepare prostaglandins and their analogues in a few steps from commonplace chemicals is still highly alluring for many researchers, especially those in the pharmaceutical industry. The brevity of Coulthard and colleagues' synthesis of PGF2α sets a new standard, and their approach should be applicable to other members of the prostaglandin class, as well as to new structures that have some of the molecular features of prostaglandins. The authors' achievement also calls to mind a much earlier groundbreaking use of succindialdehyde in chemical synthesis — Robert Robinson's synthesis of tropinone14, a precursor to the drug atropine, in 1917. Some of the power and simplicity of that classic work is seen in Coulthard and colleagues' remarkable solution to the problem of building prostaglandins.
Bergström, S., Carlson, L. A. & Weeks, J. R. Pharmacol. Rev. 20, 1–48 (1968).
Bindra, J. S. & Bindra, R. Prostaglandin Synthesis (Academic, 1977).
Mitra, A. The Synthesis of Prostaglandins (Wiley-Interscience, 1977).
Coulthard, G., Erb, W. & Aggarwal, V. K. Nature 489, 278–281 (2012).
Corey, E. J., Weinshenker, N. M., Schaaf, T. K. & Huber, W. J. Am. Chem. Soc. 91, 5675–5677 (1969).
Woodward, R. B. et al. J. Am. Chem. Soc. 95, 6853–6855 (1973).
Stork, G., Takahashi, T., Kawamoto, I. & Suzuki, T. J. Am. Chem. Soc. 100, 8272–8373 (1978).
Stork, G., Sher, P. M. & Chen, H.-L. J. Am. Chem. Soc. 108, 6384–6385 (1986).
Suzuki, M., Yanagisawa, A. & Noyori, R. J. Am. Chem. Soc. 110, 4718–4726 (1988).
List, B., Lerner, R. A. & Barbas, C. F. III J. Am. Chem. Soc. 122, 2395–2396 (2000).
Northrup, A. B. & MacMillan, D. W. C. Science 305, 1752–1755 (2004).
Mukherjee, S., Yang, J. W., Hoffmann, S. & List, B. Chem. Rev. 107, 5471–5569 (2007).
Corey, E. J. et al. J. Am. Chem. Soc. 100, 8031–8034 (1978).
Robinson, R. J. Chem. Soc. 762–768 (1917).